154 related articles for article (PubMed ID: 9700996)
1. Effect of long-term treatment with enalapril in streptozotocin diabetic and DOCA hypertensive rats.
Goyal RK; Satia MC; Bangaru RA; Gandhi TP
J Cardiovasc Pharmacol; 1998 Aug; 32(2):317-22. PubMed ID: 9700996
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.
Sevak AR; Goyal RK
Pharmacol Res; 1996; 34(5-6):201-9. PubMed ID: 9076844
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
Hakim ZS; Goyal RK
Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
[TBL] [Abstract][Full Text] [Related]
4. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
[TBL] [Abstract][Full Text] [Related]
5. Myocardial performance of STZ-diabetic DOCA-hypertensive rats.
Dai S; McNeill JH
Am J Physiol; 1992 Dec; 263(6 Pt 2):H1798-805. PubMed ID: 1481903
[TBL] [Abstract][Full Text] [Related]
6. Integrated cardiovascular function in the conscious streptozotocin-diabetic deoxycorticosterone-acetate-hypertensive rats.
Schenk J; Hebden RA; Dai S; McNeill JH
Pharmacology; 1994 Apr; 48(4):211-5. PubMed ID: 8177907
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic treatment with spirapril on biochemical parameters in streptozotocin-diabetic and spontaneously hypertensive rats.
Parulekar AA; Hakim ZS; Santani DD; Goyal RK
Indian J Exp Biol; 1997 Nov; 35(11):1182-6. PubMed ID: 9567746
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective effect of enalapril in uninephrectomized spontaneously hypertensive rats with neonatal streptozotocin-induced diabetes.
Sato Y; Iwase M; Wakisaka M; Yoshizumi H; Nunoi K; Yoshinari M; Fujishima M
Diabetes Res Clin Pract; 1995 Sep; 29(3):153-61. PubMed ID: 8591707
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of clonidine in streptozotocin-induced diabetes and DOCA-hypertensive rats.
Satia MC; Damani RR; Goyal RK
J Pharm Pharmacol; 1997 Oct; 49(10):1030-5. PubMed ID: 9364415
[TBL] [Abstract][Full Text] [Related]
10. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
[TBL] [Abstract][Full Text] [Related]
12. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC
J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804
[TBL] [Abstract][Full Text] [Related]
13. Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.
Pu Q; Amiri F; Gannon P; Schiffrin EL
J Hypertens; 2005 Feb; 23(2):401-9. PubMed ID: 15662229
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic nifedipine treatment on streptozotocin-induced diabetic rats.
Shah TS; Satia MC; Gandhi TP; Bangaru RA; Goyal RK
J Cardiovasc Pharmacol; 1995 Jul; 26(1):6-12. PubMed ID: 7564366
[TBL] [Abstract][Full Text] [Related]
16. Effects of deoxycorticosterone acetate on glucose metabolism in nondiabetic and streptozotocin-diabetic rats.
Dai S; Fraser H; McNeill JH
Can J Physiol Pharmacol; 1992 Nov; 70(11):1468-72. PubMed ID: 1296859
[TBL] [Abstract][Full Text] [Related]
17. Effect of antihypertensive treatment with alacepril on insulin resistance in diabetic spontaneously hypertensive rats.
Sato T; Nara Y; Kato Y; Yamori Y
Metabolism; 1996 Apr; 45(4):457-62. PubMed ID: 8609831
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
Duggan KA; Hodge G; Makarious MM; Charlesworth JA
Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic treatment with losartan on streptozotocin induced diabetic nephropathy.
Murali B; Goyal RK
Clin Exp Hypertens; 2001 Oct; 23(7):513-20. PubMed ID: 11710753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
